NIH-funded research R01 grant

Understanding how gastric cancer starts and grows in the stomach

Official title: Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer

Funded at Columbia University Health Sciences · NIH-11535288 · Data updated 2026-11-12

Researchers at Columbia are studying how two main types of stomach cancer begin and progress, using new mouse models and advanced single-cell and spatial analysis to map where cancer cells come from and how they change.

More Gastric Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2022
Project endAugust 31, 2027
Funding year2026
Award (this year)$98,645
NIH project number3R01CA272891-05S1
Project IDNIH-11535288 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be patients with or at risk for diffuse or intestinal gastric cancer or those contributing tissue samples for related analyses.

Less likely to help

Patients not directly linked to gastric cancer or those not participating in tissue-based studies may not benefit.

What this research studies

This grant supports creating engineered mouse models to target key tumor-suppressor genes in the stomach lining, while exposing these models to relevant environmental factors. The team will apply cutting-edge multi-omic single-cell sequencing and spatial transcriptomics to identify the cells that give rise to diffuse and intestinal gastric cancer and to understand how progression happens. The goal is to connect genetic changes with environmental influences to reveal how early events in cancer development unfold in the stomach tissue. Findings could point to new windows for early detection or targeted prevention.

Why it matters

Potential benefit: Could lead to earlier detection and better strategies to prevent or treat diffuse and intestinal gastric cancer.

How similar studies have gone: Similar multi-omic and spatial approaches have begun to unravel cellular origins in cancers, with growing evidence of their value.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Ryeom, Sandra — Columbia University Health Sciences
  • Study coordinator: Ryeom, Sandra

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.